Lab tests key to EU Plan for heart health
Summary and headline written by AI from the source article. How we work
The European Federation of Laboratory Medicine argues that widespread, reliable lab testing is essential for the European Union’s Safe Hearts Plan, a program designed to improve cardiovascular health across Europe.
The organization asserts that consistent lab data supports everything from identifying risk factors to tracking treatment effectiveness. They propose moving beyond basic health screenings to incorporate more detailed biomarker analysis and new technologies, tailoring tests to individual patient needs.
EFLM outlines five key priorities to integrate lab medicine into the plan. These include involving lab experts in planning, ensuring testing leads to personalized care, expanding access to testing, particularly through decentralized models, linking tests to value-based healthcare funding, and promoting responsible innovation alongside professional development. By bridging the gap between initial screenings and ongoing care, lab medicine can help turn the EU’s goals into tangible improvements in heart health for all Europeans.
The organization emphasizes the need for quality data and interpretation to measure the plan’s success.
